7 months ago
CYTK
AnalystsCharles DuncanCharles Duncan's Stock Forecasts
AnalystsCharles Duncan
Analyst Ranking
Top 5%
#199 out of 4587 analysts
Average Return
+15.61%
Win Rate
41%73 out of 177
Risk vs Reward
Poor
Good
Charles Duncan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Novavax IncNVAX | +2,273.26% | $9.50 | $225.46 | 2020-03-17 - 2021-03-17 | Strong Buy |
Cassava Sciences IncSAVA | +390.45% | $9.32 | $45.71 | 2020-10-23 - 2021-10-22 | Strong Buy |
Biohaven LtdBHVN | +282.44% | $13.67 | $52.28 | 2023-04-04 - 2024-04-03 | Strong Buy |
Solid Biosciences IncSLDB | +224.28% | $2.76 | $8.95 | 2023-09-22 - 2024-05-17 | Strong Buy |
Crinetics Pharmaceuticals IncCRNX | +195.74% | $17.38 | $51.40 | 2023-08-22 - 2024-05-17 | Strong Buy |
Charles Duncan Analyst Color
Get additional color on Charles Duncan's coverage of popular stocks
9 months ago
CYBN
9 months ago
CPRX
10 months ago
RETA
a year ago
PRTA
a year ago
ITCI
a year ago
HRMY
a year ago
BHVN
a year ago
ITCI
a year ago
RETA
a year ago
CLNN
a year ago
RETA
a year ago
PRTA
a year ago
FENC
2 years ago
AXSM
2 years ago
NVAX
Charles Duncan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Acadia Pharmaceuticals IncACAD | 14 | Strong Buy | $37.00 | +150.17% | Reiterates | 11 days ago |
Intra Cellular Therapies IncITCI | 12 | Strong Buy | $120.00 | +84.62% | Reiterates | a month ago |
Harmony Biosciences Holdings IncHRMY | 7 | Strong Buy | $49.00 | +68.79% | Reiterates | a month ago |
Neurocrine Biosciences IncNBIX | 5 | Strong Buy | $155.00 | +8.93% | Reiterates | a month ago |
Marinus Pharmaceuticals IncMRNS | 4 | Strong Buy | $28.00 | +2,005.26% | Reiterates | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Strong Buy | $180.00 | +65.15% | Reiterates | a month ago |
Axsome Therapeutics IncAXSM | 13 | Strong Buy | $107.00 | +39.80% | Reiterates | a month ago |
Catalyst Pharmaceuticals IncCPRX | 7 | Strong Buy | $34.00 | +106.19% | Reiterates | 2 months ago |
Karuna Therapeutics IncKRTX | 4 | Hold | $330.00 | +0.05% | Reiterates | 3 months ago |
Prothena Corp Public Ltd CoPRTA | 11 | Strong Buy | $87.00 | +286.32% | Maintains | 4 months ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $45.00 | +6.89% | Downgrades | 5 months ago |
Denali Therapeutics IncDNLI | 5 | Strong Buy | $35.00 | +70.65% | Assumes | 7 months ago |
Crinetics Pharmaceuticals IncCRNX | 3 | Strong Buy | $50.00 | -2.72% | Assumes | 7 months ago |
Cytokinetics IncCYTK | 5 | Strong Buy | $65.00 | +9.19% | Maintains | 7 months ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $5.00 | -44.13% | Initiates Coverage On | 8 months ago |
Vaxart IncVXRT | 4 | Strong Buy | $4.00 | +317.10% | Reiterates | 8 months ago |
Cybin IncCYBN | 4 | Strong Buy | $3.00 | +757.14% | Reiterates | 9 months ago |
Lucid Diagnostics IncLUCD | 4 | Strong Buy | $4.00 | +341.99% | Reiterates | 9 months ago |
Xenon Pharmaceuticals IncXENE | 3 | Strong Buy | $58.00 | +45.73% | Reiterates | 9 months ago |
Seelos Therapeutics IncSEEL | 6 | Strong Buy | $480.00 | +25,163.16% | Reiterates | 9 months ago |
Mind Medicine IncMNMD | 2 | Strong Buy | $7.00 | -14.84% | Reiterates | 9 months ago |
Lumos Pharma IncLUMO | 4 | Strong Buy | $10.00 | +293.70% | Reiterates | 9 months ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $20.00 | +67.79% | Reiterates | 9 months ago |
Biovie IncBIVI | 4 | Strong Buy | $11.00 | +2,135.77% | Reiterates | 9 months ago |
Clene IncCLNN | 5 | Strong Buy | $4.00 | +981.08% | Reiterates | 9 months ago |
Reata Pharmaceuticals IncRETA | 7 | Hold | $172.00 | -0.21% | Reiterates | 9 months ago |
Cardiol Therapeutics IncCRDL | 2 | Strong Buy | $3.00 | +38.25% | Reiterates | 9 months ago |
Stoke Therapeutics IncSTOK | 4 | Strong Buy | $14.00 | +0.72% | Maintains | 9 months ago |
Biohaven LtdBHVN | 2 | Strong Buy | $31.00 | -17.05% | Reiterates | 10 months ago |
Anavex Life Sciences CorpAVXL | 2 | Hold | $11.00 | N/A | Downgrades | a year ago |
Fennec Pharmaceuticals IncFENC | 2 | Strong Buy | $12.00 | N/A | Upgrades | a year ago |
Cognition Therapeutics IncCGTX | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Novavax IncNVAX | 6 | Strong Buy | $168.00 | N/A | Maintains | 2 years ago |
Aptinyx IncAPTX | 1 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Oramed Pharmaceuticals IncORMP | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Vtv Therapeutics IncVTVT | 3 | Strong Buy | $200.00 | N/A | Initiates Coverage On | 2 years ago |
Bionomics LimitedBNOX | 1 | Strong Buy | $52.00 | N/A | Initiates Coverage On | 2 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 4 | Strong Buy | $165.00 | N/A | Maintains | 3 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Ovid Therapeutics IncOVID | 1 | Hold | $4.00 | N/A | Downgrades | 3 years ago |
Cassava Sciences IncSAVA | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Inovio Pharmaceuticals IncINO | 4 | Hold | $144.00 | N/A | Downgrades | 4 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Geron CorpGERN | 1 | Strong Buy | $4.00 | N/A | Maintains | 4 years ago |
Halozyme Therapeutics IncHALO | 2 | Strong Buy | $39.00 | N/A | Reiterates | 4 years ago |
Cara Therapeutics IncCARA | 1 | Strong Buy | $34.00 | N/A | Reiterates | 4 years ago |
Aimmune Therapeutics IncAIMT | 2 | Strong Buy | $32.00 | N/A | Maintains | 4 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Hold | $7.00 | N/A | Reiterates | 4 years ago |
Corcept Therapeutics IncCORT | 3 | Hold | $14.00 | N/A | Downgrades | 5 years ago |
Vanda Pharmaceuticals IncVNDA | 1 | Hold | $26.00 | N/A | Initiates Coverage On | 6 years ago |
Acorda Therapeutics IncACORQ | 1 | Hold | $3,840.00 | N/A | Initiates Coverage On | 6 years ago |
Sangamo Therapeutics IncSGMO | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Altimmune IncALT | 1 | Strong Buy | $180.00 | N/A | Initiates Coverage On | 7 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Pdl Biopharma IncPDLI | 1 | Strong Buy | $4.00 | N/A | Reinstates | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.